VivoSeq
Other

Ovulation

0

Pipeline Programs↗

5

Active Trials↗

4

Companies Involved↗

Ovulation is an early-stage landscape with 0 programs across 4 companies. The most active players are Bayer, Pfizer, Agile Therapeutics.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

90/100

Attrition Rate

7/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Bayer logo

Bayer

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

PreclinicalA

Agile Therapeutics

0 programs

PreclinicalMylan Pharmaceuticals Inc logo

Mylan Pharmaceuticals Inc

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

28

clinical trials

Completed19 · 68%
Recruiting4 · 14%
Unknown status2 · 7%
Terminated2 · 7%
Not yet recruiting1 · 4%

Clinical Trials

Trial Activity

28 trials

Comparative Study Between HOMA1-IR and HOMA2-IR in Prediction of Ovulation Outcome in Women With PCOS
Recruiting·—·N/A·NCT06793904·122 enrolled
Three Dimensional Ultrasonographic Detection of Human Ovulation
Recruiting·UUniversity of Saskatchewan·Phase 4·NCT06433453·30 enrolled
Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days
Recruiting·IInnovaGyn, Inc.·Phase 2·NCT05695352·21 enrolled
Investigating Ovulation Inhibition for Use as a Contraceptive
Recruiting·Mylan Pharmaceuticals Inc logoMylan Pharmaceuticals Inc·Phase 2·NCT07365904·60 enrolled
FemiClock: Modeling Daily and Reproductive Parameters in Women: Proof of Concept and Feasibility of Analytical Methods for the Study of Female Fertility.
Not yet recruiting·UUniversity Hospital, Strasbourg, France·Preclinical·NCT07687823·30 enrolled
Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation
Completed·Pfizer logoPfizer·Phase 2·NCT00254189·60 enrolled
A Phase 2, Dose-finding, Cross-over Study to Evaluate the Effect of a NES/E2 Transdermal Gel Delivery on Ovulation Suppression in Normal Ovulating Women
Completed·PPopulation Council·Phase 2·NCT00796133·18 enrolled
A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycle Control, Ovulation Inhibition, and Pharmacokinetics in Normal Cycling Women
Completed·—·Phase 2·NCT01586000·197 enrolled
Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control
Completed·AAgile Therapeutics·Phase 2·NCT01250210·123 enrolled
"Quick-starting" of a Quadriphasic Contraceptive Pills, 1 - 3 mg Estradiol Valerate/ 2 - 3 mg Dienogest VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition
Completed·—·N/A·NCT06396208·40 enrolled
HCG Levels After Ovulation Triggering as Predictors of ICSI Outcome
Completed·MMansoura University·N/A·NCT05969834·100 enrolled
Natural Cycles With Spontaneous Versus Induced Ovulation in FET
Completed·IIstituto Clinico Humanitas·N/A·NCT03581422·2,866 enrolled
The Role of Estrogen in Luteinizing Hormone Surge and Ovulation
Completed·WWake Forest University Health Sciences·Phase 4·NCT01999569·10 enrolled
Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens
Completed·Bayer logoBayer·Phase 2·NCT00805415·209 enrolled
Effect of Piroxicam on Ovulation
Completed·Bayer logoBayer·Phase 2·NCT01320709·72 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)